Page last updated: 2024-09-04

cgs 26303 and puromycin aminonucleoside

cgs 26303 has been researched along with puromycin aminonucleoside in 1 studies

Compound Research Comparison

Studies (cgs 26303)	Trials (cgs 26303)	Recent Studies (post-2010) (cgs 26303)	Studies (puromycin aminonucleoside)	Trials (puromycin aminonucleoside)	Recent Studies (post-2010) (puromycin aminonucleoside)
33	0	2	874	3	144

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chou, M; Feldman, DL; Jeng, AY; Mogelesky, TC	1

Other Studies

1 other study(ies) available for cgs 26303 and puromycin aminonucleoside

Article	Year
Attenuation of puromycin aminonucleoside-induced glomerular lesions in rats by CGS 26303, a dual neutral endopeptidase/endothelin-converting enzyme inhibitor. Journal of cardiovascular pharmacology, 2000, Volume: 36, Issue:5 Suppl 1 Topics: Animals; Aspartic Acid Endopeptidases; Blotting, Northern; Endothelin-Converting Enzymes; Kidney Glomerulus; Male; Metalloendopeptidases; Neprilysin; Organophosphonates; Protease Inhibitors; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; RNA, Messenger; Tetrazoles	2000

Article

Year

Attenuation of puromycin aminonucleoside-induced glomerular lesions in rats by CGS 26303, a dual neutral endopeptidase/endothelin-converting enzyme inhibitor.

Journal of cardiovascular pharmacology, 2000, Volume: 36, Issue:5 Suppl 1

Topics: Animals; Aspartic Acid Endopeptidases; Blotting, Northern; Endothelin-Converting Enzymes; Kidney Glomerulus; Male; Metalloendopeptidases; Neprilysin; Organophosphonates; Protease Inhibitors; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; RNA, Messenger; Tetrazoles

2000